Optimal chemotherapy for prostate cancer

被引：0
作者：
Papandreou, Christos N. [1 ]
机构：
[1] Univ Thessaly, Sch Med, Larisa, Greece
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
[31]   Chemotherapy for oligometastatic prostate cancer [J].
Dorff, Tanya B. ;
Sweeney, Christopher J. .
CURRENT OPINION IN UROLOGY, 2017, 27 (06) :553-558
[32]   Chemotherapy for prostate cancer - Discussion [J].
Carroll, PR ;
Kantoff, PW ;
Oh, WK ;
Kelly, WK ;
Sartor, O .
UROLOGY, 2002, 60 (3A) :100-100
[33]   Chemotherapy agents and timing of chemotherapy in prostate cancer management [J].
Donohue K.M. ;
Petrylak D.P. .
Current Urology Reports, 2005, 6 (3) :224-227
[34]   Upfront Chemotherapy for Metastatic Prostate Cancer [J].
Lam, Elaine T. ;
Flaig, Thomas W. .
ONCOLOGY-NEW YORK, 2015, 29 (12) :956-962
[35]   The role of chemotherapy in metastatic prostate cancer [J].
Riaz, Irbaz B. ;
Sweeney, Christopher J. .
CURRENT OPINION IN UROLOGY, 2022, 32 (03) :292-301
[36]   Chemotherapy in the treatment of prostate cancer - Is there a role? [J].
Arianayagam, Mohan ;
Chang, Jeff ;
Rashid, Prem .
AUSTRALIAN FAMILY PHYSICIAN, 2007, 36 (09) :737-739
[37]   The evolution of chemotherapy for the treatment of prostate cancer [J].
Quinn, D. I. ;
Sandler, H. M. ;
Horvath, L. G. ;
Goldkorn, A. ;
Eastham, J. A. .
ANNALS OF ONCOLOGY, 2017, 28 (11) :2658-2669
[38]   CHEMOTHERAPY IN METASTASIZED PROSTATE-CANCER [J].
HEIMBACH, D ;
WIRTH, M ;
FROHMULLER, H .
UROLOGE-AUSGABE A, 1991, 30 (05) :329-332
[39]   The evolving role of chemotherapy in prostate cancer [J].
De Wit, R. .
EJC SUPPLEMENTS, 2005, 3 (02) :21-21
[40]   Chemotherapy for advanced prostate cancer - Reply [J].
Petrylak, DP ;
Hussain, M ;
Crawford, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (02) :201-201
12345